A pink flush settles in for an hour or two, then fades
Jose et al
References Heffernan M, Summers RJ, Thorburn A, Ogru E, Gianello R, Jiang WJ, Ng FM
Patients receiving EGRIFTA had an increased risk of developing diabetes (HbA1c level 6.5%) compared with placebo (5% vs
Potential concerns include: Unknown product quality Contamination or sterility issues Incorrect dosing Injection site reactions Allergic or immune reactions Medication interactions Hormonal or metabolic effects Unclear long-term safety Lack of monitoring Delayed treatment for an actual injury or medical condition Medical oversight is especially important for patients with autoimmune conditions, cancer history, active infections, chronic inflammatory disorders, cardiovascular concerns, hormone-sensitive conditions, or complex medication regimens
In contrast, in histiocytes of the lower dermis and subcutaneous fat, pigment was stored with increased amounts of iron and calcium, and no melanosomes were detected, suggesting a different nature of the pigment